Mouna Mnif
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mouna Mnif has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Dorra Ghorbel
Endocrinology Department, Hedi Chaker Hospital, 3029 Sfax, Tunisia
1 shared publication - Faten Hadj Kacem
Service d’endocrinologie, CHU Hédi Chaker, Sfax, Tunisie
1 shared publication - Fatma Mnif
Service d’endocrinologie et diabétologie, CHU Hédi Chaker, Sfax, Tunisie
1 shared publication - Hamza Elfekih
Faculty of Medicine of Sousse, University of Sousse, Sousse 4002, Tunisia
1 shared publication - Mohamed Abid
Service d’endocrinologie, CHU Hédi Chaker Sfax, Sfax, Tunisie
1 shared publication - Mohamed Elleuch
Service d’endocrinologie, CHU Hédi Chaker, Sfax, Tunisie
1 shared publication
Latest Publications
- Open Access
- 1 December 2019
- Published by Knowledge E DMCC in Iranian Journal of Allergy, Asthma and Immunology
- Vol. 18 (5) , 572-583
Successful Treatment of Insulin Allergy with Desensitization Therapy: A Case Report and Literature Review
Insulin therapy is an essential treatment for type 1 and uncontrolled type 2 diabetes mellitus (DM). Hypersensitivity reactions have been described since the first administration of insulin, the same as any other therapy. Despite being a rare situation nowadays, it requires careful intra-hospital monitoring and multidisciplinary management. Here, we present a case of a 57-year-old patient with type 2 DM, an average glycemic control, and both penicillin and insulin allergy. Heunderwent a desensitization protocol which allowed successfully dismiss him with intermediate-acting insulin.
- 1 December 2019
- Published by Knowledge E DMCC in Iranian Journal of Allergy, Asthma and Immunology
- Vol. 18 (5) , 572-583
Open AccessSuccessful Treatment of Insulin Allergy with Desensitization Therapy: A Case Report and Literature Review
Insulin therapy is an essential treatment for type 1 and uncontrolled type 2 diabetes mellitus (DM). Hypersensitivity reactions have been described since the first administration of insulin, the same as any other therapy. Despite being a rare situation nowadays, it requires careful intra-hospital monitoring and multidisciplinary management. Here, we present a case of a 57-year-old patient with type 2 DM, an average glycemic control, and both penicillin and insulin allergy. Heunderwent a desensitization protocol which allowed successfully dismiss him with intermediate-acting insulin.